Most cited papers in Inflammatory Myopathies and Dermatomyositis
What are the most cited papers in Inflammatory Myopathies and Dermatomyositis?
The most cited paper in Inflammatory Myopathies and Dermatomyositis is "Polymyositis and Dermatomyositis" (Anthony Bohan, James B. Peter, 1975), with 5,137 citations. Next come "Preliminary criteria for the classification of systemic sclerosis (scleroderma)" (4,957) and "2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative" (3,458).
Showing 50 of 97 papers. Every paper with more than 462 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Polymyositis and Dermatomyositis Anthony Bohan, James B. Peter · New England Journal of Medicine | 13 Feb 1975 | 5,137 |
| 2 | Preliminary criteria for the classification of systemic sclerosis (scleroderma) Alfonse T. Masi · Arthritis & Rheumatism | May 1980 | 4,957 |
| 3 | 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative Frank H J van den Hoogen et al. · Arthritis & Rheumatism | 3 Oct 2013 | 3,458 |
| 4 | Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA) Gordon C. Sharp, William S. Irvin, Eng M. Tan et al. · The American Journal of Medicine | Feb 1972 | 1,855 |
| 5 | Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease Oliver Distler, Kristin B. Highland, Martina Gahlemann et al. · New England Journal of Medicine | 20 May 2019 | 1,667 |
| 6 | 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups Ingrid E. Lundberg et al. · Annals of the Rheumatic Diseases | 27 Oct 2017 | 1,587 |
| 7 | Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management Erik S.G. Stroes et al. · European Heart Journal | 18 Feb 2015 | 1,451 |
| 8 | Polymyositis and dermatomyositis Marinos C. Dalakas, Reinhard Hohlfeld · The Lancet | Sep 2003 | 1,421 |
| 9 | Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial Jürgen Braun, Jan Brandt, Joachim Listing et al. · The Lancet | Apr 2002 | 1,265 |
| 10 | Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study Catherine Louise Hill, Yuqing Zhang, Bárður Sigurgeirsson et al. · The Lancet | 2001 | 1,197 |
| 11 | A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis Marinos C. Dalakas, Isabel Illa, James M. Dambrosia et al. · New England Journal of Medicine | 30 Dec 1993 | 1,140 |
| 12 | An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features Aryeh Fischer, Katerina M. Antoniou, Kevin M. Brown et al. · European Respiratory Journal | 9 Jul 2015 | 1,111 |
| 13 | The Syndromes of Insulin Resistance and Acanthosis Nigricans C. Ronald Kahn, Jeffrey S. Flier, Robert S. Bar et al. · New England Journal of Medicine | Apr 1976 | 1,110 |
| 14 | CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up Fabian Müller et al. · New England Journal of Medicine | 21 Feb 2024 | 1,079 |
| 15 | Myositis‐specific autoantibodies: an important tool to support diagnosis of myositis Zoë Betteridge, NJ McHugh · Journal of Internal Medicine | 25 Nov 2015 | 1,061 |
| 16 | Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis Julie A. Bjoraker, Jay Hoon Ryu, Mark Edwin et al. · American Journal of Respiratory and Critical Care Medicine | 1998 | 1,050 |
| 17 | A COMPUTER-ASSISTED ANALYSIS OF 153 PATIENTS WITH POLYMYOSITIS AND DERMATOMYOSITIS Anthony Bohan, James B. Peter, Ralph L. Bowman et al. · Medicine | Jul 1977 | 1,034 |
| 18 | A New Approach to the Classification of Idiopathic Inflammatory Myopathy Lori A. Love, Richard L. Leff, D. D. Fraser et al. · Medicine | Nov 1991 | 975 |
| 19 | 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands Jessica E. Hoogendijk, Anthony A. Amato, Bryan R.F. Lecky et al. · Neuromuscular Disorders | 30 Mar 2004 | 952 |
| 20 | Polymyositis, Dermatomyositis, and Inclusion-Body Myositis Marinos C. Dalakas · New England Journal of Medicine | 21 Nov 1991 | 948 |
| 21 | Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database Ulrich Andreas Walker, Alan Tyndall, L. Czirják et al. · Annals of the Rheumatic Diseases | 18 Jan 2007 | 938 |
| 22 | Radiographic and Pathologic Features of Spinal Involvement in Diffuse Idiopathic Skeletal Hyperostosis (DISH) DONALD L. RESNICK, Gen Niwayama · Radiology | Jun 1976 | 937 |
| 23 | Severe organ involvement in systemic sclerosis with diffuse scleroderma Virginia Steen, Thomas A. Medsger · Arthritis & Rheumatism | Nov 2000 | 928 |
| 24 | Simple method for measurement of lower extremity muscle strength Maryellen Csuka, Daniel J. McCarty · The American Journal of Medicine | 1985 | 895 |
| 25 | Scleromyxoedema-like cutaneous diseases in renal-dialysis patients Shawn E. Cowper, Howard S. Robin, Steven M. Steinberg et al. · The Lancet | Sep 2000 | 884 |
| 26 | Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population‐based study Tim Bongartz, Carlotta Nannini, Yimy F. Medina et al. · Arthritis & Rheumatism | 12 Feb 2010 | 882 |
| 27 | Identification of a family of human centromere proteins using autoimmune sera from patients with scleroderma William C. Earnshaw, Naomi F. Rothfield · Chromosoma | 1985 | 862 |
| 28 | Mitochondrial Myopathy Caused by Long-Term Zidovudine Therapy Marinos C. Dalakas, Isabel Illa, Gholam H. Pezeshkpour et al. · New England Journal of Medicine | 19 Apr 1990 | 849 |
| 29 | Inclusion body myositis and myopathies Robert C. Griggs, Valerie Askanas, Salvatore DiMauro et al. · Annals of Neurology | Nov 1995 | 841 |
| 30 | Risk of Cancer in Patients with Dermatomyositis or Polymyositis Bárður Sigurgeirsson, Bernt Lindelöf, Olof Edhag et al. · New England Journal of Medicine | 6 Feb 1992 | 796 |
| 31 | Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment Lorraine Cheryl Pelosof, David E. Gerber · Mayo Clinic Proceedings | Sep 2010 | 781 |
| 32 | Systemic Sclerosis Clodoveo Ferri, Gabriele Valentini, Franco Cozzi et al. · Medicine | Mar 2002 | 764 |
| 33 | Idiopathic Giant-Cell Myocarditis — Natural History and Treatment Leslie T. Cooper, Gerald J. Berry, Ralph W. Shabetai · New England Journal of Medicine | 26 Jun 1997 | 760 |
| 34 | Autoantibodies to a 140‐kd polypeptide, CADM‐140, in Japanese patients with clinically amyopathic dermatomyositis Shinji Sato, Michito Hirakata, Masataka Kuwana et al. · Arthritis & Rheumatism | May 2005 | 755 |
| 35 | Statin-Associated Side Effects Paul D. Thompson, Gregory A. Panza, Amanda L. Zaleski et al. · Journal of the American College of Cardiology | May 2016 | 751 |
| 36 | Neurologic Complications in Children with Enterovirus 71 Infection Chao Huang, Ching-Chuan Liu, Ying-Chao Chang et al. · New England Journal of Medicine | 23 Sep 1999 | 727 |
| 37 | Sarcoidosis and Its Neurological Manifestations Barney J. Stern, Allan Krumholz, C. Johns et al. · Archives of Neurology | Sep 1985 | 719 |
| 38 | Idiopathic inflammatory myopathies Ingrid E. Lundberg, Manabu Fujimoto, Jiří Vencovský et al. · Nature Reviews Disease Primers | 2 Dec 2021 | 708 |
| 39 | Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo‐phase trial Chester V. Oddis, Ann M. Reed, Rohit Aggarwal et al. · Arthritis & Rheumatism | 2 Nov 2012 | 703 |
| 40 | Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy Andrew Lee Mammen, Tae Chung, Lisa Christopher‐Stine et al. · Arthritis & Rheumatism | 19 Nov 2010 | 699 |
| 41 | Idiopathic Pulmonary Fibrosis Ronald G. Crystal, Jack D. Fulmer, William Clifford Roberts et al. · Annals of Internal Medicine | Dec 1976 | 691 |
| 42 | Autoantibodies in Systemic Sclerosis Virginia Steen · Seminars in Arthritis and Rheumatism | Aug 2005 | 689 |
| 43 | Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial Dinesh Khanna et al. · The Lancet | 6 May 2016 | 686 |
| 44 | Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial Dinesh Khanna et al. · The Lancet Respiratory Medicine | 29 Aug 2020 | 675 |
| 45 | Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases Boris Hinz, David Lagares · Nature Reviews Rheumatology | 2 Dec 2019 | 644 |
| 46 | Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells Kiichi Arahata, Andrew G. Engel · Annals of Neurology | Aug 1984 | 632 |
| 47 | Rhabdomyolysis Giorgia Melli, Vinay Chaudhry, David R. Cornblath · Medicine | Nov 2005 | 631 |
| 48 | Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis Steven A. Greenberg, Jack L. Pinkus, Geraldine S. Pinkus et al. · Annals of Neurology | 25 Apr 2005 | 620 |
| 49 | Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty‐year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis Martial Koenig, France Joyal, Marvin J. Fritzler et al. · Arthritis & Rheumatism | 26 Nov 2008 | 616 |
| 50 | Calcium-Channel Antibodies in the Lambert–Eaton Syndrome and Other Paraneoplastic Syndromes Vanda A. Lennon, Thomas J. Kryzer, Guy E. Griesmann et al. · New England Journal of Medicine | Jun 1995 | 610 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.